Navigation Links
XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
Date:8/6/2008

XTELL has launched a commercial biorepository service, bioVAULT, which stores, manages and processes large numbers of biological specimens. BioVAULT is targeting scientific and pharmaceutical companies investigating new drug and diagnostic development.

Athens, OH (PRWEB) August 5, 2008 -- XTELL announced today the launch of its commercialized, independent biorepository service stemming from its collaborations with The Ohio University Endocrine Diseases Biorepository. XTELL's "bioVAULT" service will provide storage of biological samples derived from human/animal serum and tissues with 100% guaranteed confidentiality. BioVAULT will allow clinicians and researchers alike to facilitate and link patient/family medical history.

XTELL is a biotechnology company founded in 2001, dedicated to both the development of biological specimen storage and electronic medical record software.

A large part of XTELL's success has been from a direct partnership with Ohio University's Diabetes Center in creating a biorepository designed specifically for fundamental and translational research. Samples include DNA, RNA, and protein extracted from blood serum in patients living in a region of the United States with a high prevalence of diabetes and endocrine-related disease. XTELL has developed one of the most advanced diabetes biorepositories of its kind, with a state-of-the-art collection and storage facility.

BioVAULT is now capable of storing, managing and processing large numbers of biological specimens. BioVAULT is targeting scientific and pharmaceutical companies investigating new drug and diagnostic development, as well as universities. "Biorepositories are now critical in understanding the molecular mechanisms of disease and for the development of new therapeutics, " said Anthony Schwartz, President of XTELL.


XTELL is privately held and located in Athens, Ohio and is seeking new investors for building up its infrastructure as well as to secure its long-term growth.

Additional information is available at: http://www.xtell.com

Contact:
XTELL
Anthony Schwartz
President
Telephone: 1.800.314.0735
E-mail: info @ xtellnetworks.com

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1174534.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community
2. Ingenuity Systems Launches Analysis Services
3. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
4. iNutrition Launches New Fission Fruit Nutrition Bars
5. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
6. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
7. Ranbaxy Launches Omeprazole 40 mg Capsules
8. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
9. GeneNews launches worlds first blood test for colorectal cancer screening
10. Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi
11. Health Market Science Launches Clinical Investigators(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies 
(Date:12/9/2016)... India , December 9, 2016 According ... & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, ... Forecasts to 2021" published by MarketsandMarkets, the global market is expected ... in 2016, at a CAGR of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... ... December 08, 2016 , ... Lajollacooks4u, San Diego’s premier team building events and ... events, new program offerings and company expansion. , This is largely due ... groups of over 30 people. Ever since, Lajollacooks4u has seen significant demand for its ...
(Date:12/8/2016)... AskLinkerReports.com has published a report on Amyloglucosidase Market ... Market Research Report. From a basic outline of the Amyloglucosidase ... covered in the report. This report projects investment feasibility analysis, ... Amyloglucosidase industry. ... , Complete report on ...
(Date:12/8/2016)... Iowa , Dec. 8, 2016 Eurofins announces the ... Food and President of Eurofins Scientific Inc. (ESI). ... with his proven professional and entrepreneurial experience in leading international business ... the US food testing market to uphold Eurofins, status as the ... ...
Breaking Biology Technology:
(Date:12/6/2016)... , Dec. 6, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... announced today a five (5) year funding commitment ... to expand the rehabilitation and reentry support to ... History Established in 2004, the Prison Entrepreneurship Program ...
(Date:12/2/2016)... 1, 2016   SoftServe , a global ... , an electrocardiogram (ECG) biosensor analysis system for ... IoT asset. The smart system ensures device-to-device communication ... wheel and mobile devices to easily ,recognize, and ... As vehicle technology advances, so too must the ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):